|
|
 |
[ 2006 ] [ 2005 ] [ 2004 ] [ 2003 ]
NOVEL CANCER THERAPY EMERGES FROM FAU'S CENTER OF EXCELLENCE IN BIOMEDICAL AND MARINE BIOTECHNOLOGY
(June 21, 2006) - BOCA RATON, Fla., -- Florida Atlantic University announced today an exclusive license agreement with CHS Resources LLC for a novel cancer therapy which has emerged from its Center of Excellence in Biomedical and Marine Biotechnology. CHS Resources will develop and ultimately commercialize patent pending technology for the treatment of skin cancer.
Click here for more >>
FAU RESEARCHERS WIN $4 MILLION GRANT TO STUDY, HIV, CANCER, HEART DISEASE
(June 14, 2005) - BOCA RATON, Fla., -- Six Florida Atlantic University scientists now
have $4 million to research HIV, heart disease and cancer in the next four years, thanks
to a grant awarded by the National Institutes of Health, officials announced Monday.
Click here for more >>
FLORIDA LAWMAKERS ARE ANCHORING STEM CELL CAMPAIGN ON NEW SCRIPPS RESEARCH INSTITUTE
(August 15, 2005) - WEST PALM BEACH, Fla., -- Lately when Palm Beach County Commissioner
Burt Aaronson speaks to a crowd, he starts with a series of questions.
"Who knows someone with Alzheimer's, diabetes, a spinal cord injury,
Parkinson's or heart problems?" he asks. "And who wants their tax dollars to
search for the most promising cures?"
Click here for more >>
FAU RESEARCHERS WIN $4 MILLION GRANT TO STUDY, HIV, CANCER, HEART DISEASE
(June 14, 2005) - BOCA RATON, Fla., -- Six Florida Atlantic University scientists now
have $4 million to research HIV, heart disease and cancer in the next four years, thanks
to a grant awarded by the National Institutes of Health, officials announced Monday.
Click here for more >>
NABI BIOPHARMACEUTICALS DEDICATES ITS NEW VACCINE MANUFACTURING FACILITY
(June 2, 2005) - BOCA RATON, Fla., - Nabi Biopharmaceuticals (Nasdaq: NABI - News) announced today that it has officially opened its new
vaccine manufacturing facility in Boca Raton, Florida. The company completed construction in just eight months, a significant
accomplishment for a facility that will be uniquely able to produce commercial quantities of StaphVAX®
[Staphylococcus aureus Polysaccharide Conjugate Vaccine] to meet global demand. StaphVAX is currently in Phase III
development to prevent S. aureus infections in end-stage renal (kidney) disease (ESRD) patients.
Click here for more >>
DYADIC APPROVED FOR LISTING ON THE AMERICAN STOCK EXCHANGE
(May 17, 2005) - JUPITER, Fla. Ü (via Business Wire) Ü Dyadic International, Inc. (OTCBB: DYAD), a biotechnology
company, today announced that it has been approved for listing on the American Stock Exchange ("Amex"). Dyadic's
common stock is expected to begin trading on the Amex under the ticker symbol "DIL" on May 26, 2005.
Click here for more >>
DYADIC ANNOUNCES SUCCESSFUL COMPLETION OF SEQUENCING OF C1 FUNGAL GENOME -
DYADIC'S PROPRIETARY SOURCE OF PROTEINS AND ENZYMES
(May 9, 2005) -
Dyadic International, Inc. (OTCBB: DYAD), a biotechnology company,
today announced the early completion of the genome sequence of Dyadic's C1 fungus by
Agencourt Bioscience Corporation, Beverly, Massachusetts. Dyadic has spawned a successful
business based on the ability of the C1 organism to produce large volumes of low cost
industrial enzymes for industrial, textile, and agricultural applications.
Click here for more >>
FLORIDA'S CENTERS OF EXCELLENCE
GAINESVILLE.COM (April 29, 2005) - The Florida Legislature is suffering from an "embarrassment of riches" this
year. Thanks to a healthy economy, lawmakers have a $2 billion surplus from which to fund the
state's needs. This is a great time to invest a tiny portion of that surplus in Florida's
economic future.
Click here for more >>
NEW FUNDING WARRANTED
SOUTH FLORIDA SUN-SENTINEL EDITORIAL BOARD (Apr. 27, 2005) -
Florida lawmakers have a proposal before them that would simultaneously fund higher education
and boost investment in technology businesses. That's a two-for-one special they shouldn't pass up.
They should support a call for $50 million in renewed funding for the Centers of Excellence program.
Click here for more >>
HARBOR BRANCH HUNTS DEEP WATERS FOR MEDICAL CURES
ELIOT KLEINBERG - PALM BEACH POST STAFF WRITER (Apr. 14, 2005) -
Deep-sea sponges are technically animals, but they can't move. So nature has given them chemicals
to ward off predators. Scientists realized years ago that those substances sometimes fight cancer, Alzheimer's disease
and other human ailments.
Click here for more >>
SCRIPPS IS CATALYST FOR FLORIDA'S LIFE SCIENCES INDUSTRY
JONATHAN E. COLE AND LESLIE J. CROLAND - EDWARDS & ANGELL -
If recent initiatives undertaken by the Sunshine State are any indication of the future, the opportunitues for risk capital
investment within Florida will become more attractive over the next five to 10 years.
Click here for PDF download >>
SEARCHING THE DEPTHS OF THE STRAITS OF FLORIDA FOR DISEASE CURES
MARK SCHROPE - HBOI PRESS RELATIONS (Apr. 3, 2005) -
Harbor Branch Biomedical Expedition to include first submersible exploration of remote Cay Sal Bank as well as
dives throughout the western Bahamas and the Miami Terrace.
Click here for more >>
ALREADY, SCRIPPS HELPS BIOTECHS
KRIS HUNDLEY - TIMES STAFF WRITER (Feb. 23, 2005) -
The biotech research institute has found "hidden gems" in Florida, illustrating what might
come in the future.
Click here for more >>
|
|
